文献速递临床试验与 GCP医学人工智能与信息学

将康复带回家:用电子健康平台治疗卒中患者——RGS@home随机临床试验的研究方案

Bringing rehabilitation home with an e-health platform to treat stroke patients: study protocol of a randomized clinical trial (RGS@home).
PubMed 文献 · Trials · 2022-06-20

RGS@home是一项在西班牙、瑞典和法国医院开展的随机纵向临床试验,评估康复游戏系统(RGS)联合标准护理是否优于单纯标准护理,以促进卒中患者在医院和家中的功能恢复。干预持续3个月,基线及3、6、12个月评估,已招募90例(平均年龄60岁,卒中后≥30天),预计2023年7月结束。

要点

  • RGS是基于云的系统,利用虚拟现实、动作捕捉和可穿戴设备提供AI增强康复。
  • 研究评估RGS联合标准护理对比单纯标准护理对卒中患者功能恢复的优效性。
  • 已招募90例(平均年龄60岁,卒中后≥30天),试验预计2023年7月结束。

核心结论

  • 预测患者恢复改善、接受度高且成本降低,因从临床到家庭康复的软着陆。
  • 数据将评估家庭治疗处方是否能对抗功能恶化并改善生活质量,同时为欧洲医院确定在线和远程评估、诊断和干预的新标准。

研究设计与样本

  • 随机纵向临床试验,评估RGS干预联合标准护理是否优于单纯标准护理。
  • 与西班牙、瑞典和法国的医院合作,纳入亚急性和慢性期卒中住院和门诊患者。
  • 干预持续3个月,基线及3、6、12个月评估。
  • 已招募90例(平均年龄60岁,卒中后≥30天),为预期参与患者的三分之一。

主要发现

  • 截至目前已招募90例(平均年龄60岁,卒中后≥30天)。
  • 试验预计2023年7月结束。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a pressing need for scalable healthcare solutions and a shift in the rehabilitation paradigm from hospitals to homes to tackle the increase in stroke incidence while reducing the practical and economic burden for patients, hospitals, and society. Digital health technologies can contribute to addressing this challenge; however, little is known about their effectiveness in at-home settings. In response, we have designed the RGS@home study to investigate the effectiveness, acceptance, and cost of a deep tech solution called the Rehabilitation Gaming System (RGS). RGS is a cloud-based system for delivering AI-enhanced rehabilitation using virtual reality, motion capture, and wearables that can be used in the hospital and at home. The core principles of the brain theory-based RGS intervention are to deliver rehabilitation exercises in the form of embodied, goal-oriented, and task-specific action. METHODS: The RGS@home study is a randomized longitudinal clinical trial designed to assess whether the combination of the RGS intervention with standard care is superior to standard care alone for the functional recovery of stroke patients at the hospital and at home. The study is conducted in collaboration with hospitals in Spain, Sweden, and France and includes inpatients and outpatients at subacute and chronic stages post-stroke. The intervention duration is 3 months with assessment at baseline and after 3, 6, and 12 months. The impact of RGS is evaluated in terms of quality of life measurements, usability, and acceptance using standardized clinical scales, together with health economic analysis. So far, one-third of the patients expected to participate in the study have been recruited (N = 90, mean age 60, days after stroke ≥ 30 days). The trial will end in July 2023. DISCUSSION: We predict an improvement in the patients' recovery, high acceptance, and reduced costs due to a soft landing from the clinic to home rehabilitation. In addition, the data provided will allow us to assess whether the prescription of therapy at home can counteract deterioration and improve quality of life while also identifying new standards for online and remote assessment, diagnostics, and intervention across European hospitals. TRIAL REGISTRATION: C linicalTrials.gov NCT04620707. Registered on November 3, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mura A, Maier M, Ballester BR, et al. Bringing rehabilitation home with an e-health platform to treat stroke patients: study protocol of a randomized clinical trial (RGS@home). Trials. 2022. PMID: 35725616. doi:10.1186/s13063-022-06444-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。